| |
| |
|
| Insider
Information: |
Mcmahon Gerald Phd |
| Relationship: |
President and CEO, Dir... |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
445,596 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,234,026 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
445,596 |
|
|
| Total
Value |
$6,234,026 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Poniard Pharmaceuticals |
PARD |
Director |
2011-06-09 |
73,826 |
2004-05-25 |
0 |
Premium* |
|
|
Mateon Therapeutics Inc |
MATN |
Director |
2014-07-02 |
18,611 |
2013-01-02 |
0 |
Premium* |
|
|
Celldex Therapeutics Inc |
CLDX |
Director |
2018-12-03 |
180,697 |
|
0 |
Premium* |
|
|
Harpoon Therapeutics, Inc. |
HARP |
President and CEO, Dir... |
2019-06-05 |
172,462 |
2019-05-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CLDX |
Celldex Therapeutics Inc |
Director |
– • – |
2018-02-01 |
4 |
D |
$2.76 |
$9,425 |
D/D |
(3,415) |
210,156 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
Director |
– • – |
2017-06-01 |
4 |
D |
$2.83 |
$8,119 |
D/D |
(2,869) |
225,822 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
Director |
– • – |
2018-01-02 |
4 |
D |
$2.84 |
$10,409 |
D/D |
(3,665) |
213,571 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
Director |
– • – |
2017-10-02 |
4 |
D |
$2.86 |
$9,186 |
D/D |
(3,212) |
223,660 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
Director |
– • – |
2017-12-01 |
4 |
D |
$3.00 |
$9,636 |
D/D |
(3,212) |
217,236 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
Director |
– • – |
2017-05-01 |
4 |
D |
$3.33 |
$9,554 |
D/D |
(2,869) |
228,691 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
Director |
– • – |
2017-03-01 |
4 |
D |
$3.54 |
$116,562 |
D/D |
(32,927) |
234,429 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
Director |
– • – |
2017-04-03 |
4 |
D |
$3.61 |
$10,357 |
D/D |
(2,869) |
231,560 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Chief Executive Officer |
• • – |
2008-03-06 |
4 |
B |
$3.93 |
$15,327 |
D/D |
3,900 |
4,733 |
2.81 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
President and CEO |
• • – |
2019-05-14 |
4 |
B |
$10.16 |
$10,157 |
D/D |
1,000 |
3,000 |
2.81 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
President and CEO |
• • – |
2019-05-03 |
4 |
B |
$10.53 |
$10,530 |
D/D |
1,000 |
1,000 |
2.81 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
President and CEO |
• • – |
2019-05-08 |
4 |
B |
$10.56 |
$10,559 |
D/D |
1,000 |
2,000 |
2.81 |
- |
|
37 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
